Cite
Hamed MA, Nakata S, Shiogama K, et al. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity. Clin Exp Otorhinolaryngol. 2017;10(3):213-220doi: 10.21053/ceo.2016.01263.
Hamed, M. A., Nakata, S., Shiogama, K., Suzuki, K., Sayed, R. H., Nishimura, Y., Iwata, N., Sakurai, K., Badawy, B. S., Inada, K. I., Tsuge, H., & Tsutsumi, Y. (2017). Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity. Clinical and experimental otorhinolaryngology, 10(3), 213-220. https://doi.org/10.21053/ceo.2016.01263
Hamed, Mahmood A, et al. "Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity." Clinical and experimental otorhinolaryngology vol. 10,3 (2017): 213-220. doi: https://doi.org/10.21053/ceo.2016.01263
Hamed MA, Nakata S, Shiogama K, Suzuki K, Sayed RH, Nishimura Y, Iwata N, Sakurai K, Badawy BS, Inada KI, Tsuge H, Tsutsumi Y. Cytokeratin 13, Cytokeratin 17, and Ki-67 Expression in Human Acquired Cholesteatoma and Their Correlation With Its Destructive Capacity. Clin Exp Otorhinolaryngol. 2017 Sep;10(3):213-220. doi: 10.21053/ceo.2016.01263. Epub 2017 Jan 12. PMID: 28073243; PMCID: PMC5545701.
Copy
Download .nbib